HOLD Alapkezelo holds 10.4% MediWound stake

Rhea-AI Filing Summary

MediWound Ltd. (MDWD) reports that HOLD Alapkezelo Zrt., a Hungarian investment manager, has filed Amendment No. 2 to its Schedule 13G/A, updating its ownership in the company. HOLD Alapkezelo Zrt. is deemed to beneficially own 1,348,323 common shares of MediWound.

This position represents 10.4% of MediWound’s common stock, based on 12,910,278 shares outstanding as of June 30, 2026, as referenced from MediWound’s Form 6-K filed on August 13, 2026. HOLD Alapkezelo Zrt. reports sole voting and sole dispositive power over all 1,348,323 shares and no shared voting or dispositive power.

Key Figures

Shares beneficially owned by HOLD Alapkezelo Zrt.: 1,348,323 shares of Common Stock Percent of class owned by HOLD Alapkezelo Zrt.: 10.4% Shares outstanding: 12,910,278 shares of common stock +2 more

5 metrics

Shares beneficially owned by HOLD Alapkezelo Zrt. 1,348,323 shares of Common Stock Beneficial ownership reported in Schedule 13G/A Amendment No. 2

Percent of class owned by HOLD Alapkezelo Zrt. 10.4% Percentage of MediWound common stock class reported as owned

Shares outstanding 12,910,278 shares of common stock Shares of MediWound common stock outstanding as of June 30, 2026

Sole voting power 1,348,323 shares Shares over which HOLD Alapkezelo Zrt. has sole voting power

Sole dispositive power 1,348,323 shares Shares over which HOLD Alapkezelo Zrt. has sole dispositive power

Key Terms

beneficial ownership, Sole Voting Power, Sole Dispositive Power, Percent of class, +1 more

5 terms

beneficial ownership financial

"HOLD Alapkezelo Zrt. have been deemed to have the beneficial ownership of 1,348,323"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

Sole Voting Power financial

"5 | Sole Voting Power 1,348,323.00 6 | Shared Voting Power 0.00"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

Sole Dispositive Power financial

"7 | Sole Dispositive Power 1,348,323.00 8 | Shared Dispositive Power 0.00"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

Percent of class financial

"(b) | Percent of class: HOLD Alapkezelo Zrt: 10.4%"

Percent of class is the portion of a specific category of securities—such as a company’s common shares, preferred shares, or a bond series—that takes part in or approves a corporate action (vote, consent, tender, etc.). Investors watch this number because it reveals how much support or opposition exists within that particular shareholder group; like counting how many members of a club back a proposal, it can determine whether a plan passes or how influence is distributed.

Schedule 13G/A regulatory

"Amendment No. 2 to its Schedule 13G/A, updating its ownership"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

FAQ

How many MediWound Ltd. (MDWD) shares does HOLD Alapkezelo Zrt. own?

HOLD Alapkezelo Zrt. reports beneficial ownership of 1,348,323 MediWound common shares. The filing states this number explicitly and ties it to sole voting and dispositive power over all of these shares.

What percentage of MediWound (MDWD) does HOLD Alapkezelo Zrt. hold?

HOLD Alapkezelo Zrt. reports owning 10.4% of MediWound’s common stock. This percentage is calculated based on 12,910,278 shares outstanding as of June 30, 2026, as referenced from MediWound’s Form 6-K.

What is the total number of MediWound (MDWD) shares outstanding used in this 13G/A?

The ownership percentages are based on 12,910,278 shares of MediWound common stock outstanding as of June 30, 2026, according to MediWound’s Form 6-K filed on August 13, 2026.

Does HOLD Alapkezelo Zrt. have sole or shared voting power over MDWD shares?

HOLD Alapkezelo Zrt. reports sole voting power over 1,348,323 MediWound common shares and no shared voting power. It also reports the same figures for dispositive power over these shares.

Who signed the Schedule 13G/A amendment for MediWound (MDWD)?

The amendment was signed by Daniel Moricz, identified as Chief Investment Officer of HOLD Alapkezelo Zrt., dated 08/28/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/28/2026 - 08:45 AM Accepted by SEC EDGAR 08/28/2026 - 06:24 AM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)

MediWound Ltd.

(Name of Issuer)

Common Shares

(Title of Class of Securities)

M68830104

(CUSIP Number)

08/27/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): M68830104

1

Names of Reporting Persons

HOLD Alapkezelo Zrt.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

HUNGARY

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 1,348,323.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 1,348,323.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,348,323.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

10.4 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

Item 1.
(a)	Name of issuer: MediWound Ltd.
(b)	Address of issuer's principal executive offices: 42 HAYARKON STREET, YAVNE, ISRAEL, 8122745
Item 2.
(a)	Name of person filing: HOLD Alapkezelo Zrt. (HUNGARY)
(b)	Address or principal business office or, if none, residence: H-1123 Budapest, Alkotas u. 50., Hungary
(c)	Citizenship: Hungarian
(d)	Title of class of securities: Common Shares
(e)	CUSIP No.: M68830104
Item 4.	Ownership
(a)	Amount beneficially owned: The percentage set forth in Row 13 of the cover page for each Reporting Person is based upon 12,910,278 shares of the Issuers common stock outstanding as of June 30, 2026, in accordance with Issuer's 6-K filed on Agusut 13, 2026. HOLD Alapkezelo Zrt. have been deemed to have the beneficial ownership of 1,348,323 shares of common stock representing the beneficial ownership of approximately 10.4% of the common stocks.
(b)	Percent of class: HOLD Alapkezelo Zrt: 10.4%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: HOLD Alapkezelo Zrt.: 1,348,323 shares of Common Stock
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: HOLD Alapkezelo Zrt.: 1,348,323 shares of Common Stock
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

HOLD Alapkezelo Zrt.

Signature:	Daniel Moricz
Name/Title:	Chief Investment Officer
Date:	08/28/2026